{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Fourteen years after Eli Lilly introduced a small green and white capsule called Prozac, antidepressants have mushroomed from a modest market into a $12 billion industry. And Americans, little by little, are coming to think of depression as an illness like any other, a topic discussed on dates and at dinner parties. But the euphoria that greeted the arrival of the generation of drugs that Prozac heralded has faded.", "headline": {"main": "Antidepressants Lift Clouds, But Lose 'Miracle Drug' Label"}, "abstract": "Euphoria that greeted arrival of new generation of antidepressant drugs when Eli Lilly introduced Prozac 14 years ago has faded; studies indicate while millions are helped by antidepressants, including estimated 35 to 45 percent of those who take them, 55 to 65 percent are not helped nearly as much; while some people experience no side effects, for others side effects make drugs unusable, or simply not worth trouble; many patients end up on merry-go-round of medication trials, switching repeatedly from one drug to another or combining drugs to maximize effects; market for antidepressants, which in 1998 grew by 24 percent, is expected to expand by only 5 percent in 2002--situation that has sent pharmaceutical companies scrambling to find new molecules that are more effective and have fewer side effects; companies are tweaking chemical structures of existing drugs and harnessing old standbys for new uses and marketing them for everything; anaylsts say industry needs new class of drugs, one that will have as much impact, clinically and financially, as Prozac did 14 years ago; graphs; photos (L)", "print_page": "1", "word_count": 3114, "_id": "4fd21cfc8eb7c8105d79d81b", "snippet": "Fourteen years after Eli Lilly introduced a small green and white capsule called Prozac, antidepressants have mushroomed from a modest market into a $12 billion industry. And Americans, little by little, are coming to think of depression as an...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/06/30/us/antidepressants-lift-clouds-but-lose-miracle-drug-label.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "LILLY, ELI, & CO"}, {"name": "subject", "value": "MARKETING AND MERCHANDISING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "PROZAC (DRUG)"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}], "byline": {"organization": "The follog article wd by Erica Goode, Melody Petersen and Andrew Pollack and wwritten by Ms. Goode", "original": "The following article was reported by Erica Goode, Melody Petersen and Andrew Pollack and was written by Ms. Goode", "person": []}, "document_type": "article", "pub_date": "2002-06-30T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The Supreme Court today added two important cases on health care to the docket for its next term, including a closely watched case from Maine on the state's effort to force drug manufacturers to reduce their prices to Maine residents. Both new cases reflect efforts by state governments to move ahead with health care policy in the absence of action by Congress. The second case is a challenge to a Kentucky law, similar to laws on the books in half the states, that requires managed care plans to accept any doctor who meets their qualifications and who wants to join.", "headline": {"main": "Justices Accept Case on Maine's Drug Discount Program"}, "abstract": "Supreme Court agrees to hear Pharmaceutical Research and Manufacturers of America appeal of Appeals Court ruling upholding Maine law that seeks to use federal Medicaid law as leverage with drug manufacturers and wholesalers to win negotiated discounts on prices paid by state residents who lack insurance coverage for drugs; agrees to hear managed care industry challenge to Kentucky law that requires managed care plans to accept any doctor who meets their qualifications and who wants to join; such laws, sought by doctors as protection against dismissal by plans for recommending too many treatments or complaining about conditions, have been passed by 25 states; plans hold limited pool of doctors is essential to holding down costs (M)", "print_page": "10", "word_count": 974, "_id": "4fd238e18eb7c8105d7cc066", "snippet": "The Supreme Court today added two important cases on health care to the docket for its next term, including a closely watched case from Maine on the state's effort to force drug manufacturers to reduce their prices to Maine residents.    Both new...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/06/29/us/justices-accept-case-on-maine-s-drug-discount-program.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "KENTUCKY"}, {"name": "glocations", "value": "MAINE"}, {"name": "organizations", "value": "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA"}, {"name": "organizations", "value": "SUPREME COURT"}, {"name": "subject", "value": "HEALTH MAINTENANCE ORGANIZATIONS AND MANAGED CARE"}, {"name": "subject", "value": "STATES (US)"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "MEDICAID"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Linda", "lastname": "GREENHOUSE"}], "original": "By LINDA GREENHOUSE"}, "document_type": "article", "pub_date": "2002-06-29T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 2, "offset": 0, "time": 33}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}